Additionally, this review explores how SARS-CoV-2 triggers cytokine storms through interleukins, immature blood cells, and CD71+ erythroid cells, providing novel insights into the management of haematological manifestations and immune responses in patients with COVID-19. This evidence concerns the gene TFRC and COVID-19.